VADACCA, MARTA
 Distribuzione geografica
Continente #
AS - Asia 1.863
NA - Nord America 117
EU - Europa 82
SA - Sud America 7
AF - Africa 1
OC - Oceania 1
Totale 2.071
Nazione #
SG - Singapore 1.758
US - Stati Uniti d'America 116
HK - Hong Kong 53
CN - Cina 46
IT - Italia 28
GB - Regno Unito 20
NL - Olanda 10
DE - Germania 8
BR - Brasile 7
FI - Finlandia 4
FR - Francia 4
CZ - Repubblica Ceca 3
IN - India 2
JP - Giappone 2
PL - Polonia 2
AU - Australia 1
ES - Italia 1
LU - Lussemburgo 1
MX - Messico 1
SA - Arabia Saudita 1
TR - Turchia 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 2.071
Città #
Hong Kong 53
Ashburn 34
Singapore 34
Hefei 22
Boardman 21
London 19
Rome 16
Shanghai 14
Council Bluffs 10
Amsterdam 9
Jaguariúna 7
Los Angeles 6
San Francisco 4
Washington 4
Brno 3
Naples 3
Brooklyn 2
Charlotte 2
Guangzhou 2
Helsinki 2
Munich 2
New York 2
Pune 2
Tokyo 2
Turku 2
Warsaw 2
West Jordan 2
Xingtai 2
Canberra 1
Chicago 1
Cleveland 1
Frankfurt am Main 1
Handan 1
Las Vegas 1
Lecce 1
Luxembourg 1
Manchester 1
Mexico City 1
Montpellier 1
Newark 1
Nuremberg 1
Philadelphia 1
Riyadh 1
San Diego 1
Santa Clara 1
Schaumburg 1
Shenzhen 1
Sona 1
The Dalles 1
Totale 304
Nome #
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 191
Retroperitoneal fibrosis and ankylosing spondylitis: which links? 178
Relationship between leptin and regulatory T cells in systemic lupus erythematosus: preliminary results 169
Leptin in immuno-rheumatological diseases 164
Ii-key/insulin MHC class-II antigenic epitope peptides in type 1 diabetes 162
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups 156
Detection of T cell response to insulin and GAD in Type 1 diabetes using the Ii-Key-hybrid technique 153
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 144
Ii-key/MHC class II epitope hybrid technology to detect T cell response to insulin and GAD in type 1 diabetes. 96
Identification of a new method to detect t cell response in type 1 diabetes 80
A novel approach to study T cell response to Ii-KEY/MHC class II epitope hybrid peptides in type 1 diabetes 74
Leptin in autoimmune mechanisms of systemic rheumatic diseases 74
Ii-key/MHC class II epitope hybrid technology and ELISPOT as say in type 1 diabetes 73
Real-life survey on severe asthma patients during COVID-19 lockdown in Italy 63
Immunological and homeostatic pathways of alpha -1 antitrypsin: a new therapeutic potential 55
Increased COVID-19 mortality in patients with rheumatic diseases: results from the CONTROL-19 study by the Italian Society for Rheumatology 55
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis 51
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia 40
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases 39
Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study 31
The IL33/ST2 axis in Sjogren syndrome in relation to disease activity 19
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechanism at the basis of the "hyperferritinemic syndromes" 17
The Relationship Between Metabolic Syndrome and Pain Catastrophizing in Psoriatic Arthritis 6
Totale 2.090
Categoria #
all - tutte 8.031
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.031


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202219 0 0 0 0 0 0 0 0 2 1 0 16
2022/202334 1 4 0 0 16 0 1 0 1 0 11 0
2023/202478 1 8 6 4 8 32 0 0 2 3 7 7
2024/20251.954 15 4 22 10 10 24 10 3 71 119 777 889
2025/20265 5 0 0 0 0 0 0 0 0 0 0 0
Totale 2.090